Sundar Subramaniam

A founding member of Mablytics, Sundar has more than 30 years of experience leading the development of many successful tech and biotech companies, from both the technology and governance sides. His list of past and current endeavors is quite varied and extensive, and includes such accomplishments as holding directorial roles at smartShift, MedMinder, Intigua, and Knome to name just a few. Sundar was an original investor and CEO of Sialix/Siamab, where he was instrumental in directing company strategy, management, and fundraising, leading to a $202 million exit via acquisition in 2019. He is also a founder at IBCC, and chairman and CEO from 1988 to the present, as well as a chairman or CEO and founder of 5 companies that had IPOs, 2 of which were over $1 billion. Sundar has lectured at MIT and Harvard and is an adjunct assistant professor of finance at Brandeis University. Sundar received his B.S. in economics and computer science from Brandeis University, an MBA from MIT, and an M.S. from the Harvard-MIT Division of Health Sciences and Technology.